Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Myeloid Derived Suppressive Cells (MDSCs) and Cancer Stem Cells and Their Cross Talks in Non-Small Cell Lung Cancer (NSCLC)

NCT06024226 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT06024226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06024226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Myeloid Derived Suppressive Cells (MDSCs) and Cancer Stem Cells and Their Cross Talks in Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
December 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, lung neoplasms, myeloid-derived suppressor cells